These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9971820)

  • 21. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome.
    Heslin DJ; Murcia P; Arnaud F; Van Doorslaer K; Palmarini M; Lenz J
    J Virol; 2009 Jan; 83(2):1105-14. PubMed ID: 19004950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of a human endogenous retroviral HERV-H element with an open env reading frame.
    Lindeskog M; Mager DL; Blomberg J
    Virology; 1999 Jun; 258(2):441-50. PubMed ID: 10366582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HERV-IP-T47D, a novel type C-related human endogenous retroviral sequence derived from T47D particles.
    Seifarth W; Baust C; Schön U; Reichert A; Hehlmann R; Leib-Mösch C
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):471-80. PubMed ID: 10772533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of endogenous retroviral reading frames in the human genome.
    Villesen P; Aagaard L; Wiuf C; Pedersen FS
    Retrovirology; 2004 Oct; 1():32. PubMed ID: 15476554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
    Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
    J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome.
    Lavie L; Medstrand P; Schempp W; Meese E; Mayer J
    J Virol; 2004 Aug; 78(16):8788-98. PubMed ID: 15280487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.
    Golan M; Hizi A; Resau JH; Yaal-Hahoshen N; Reichman H; Keydar I; Tsarfaty I
    Neoplasia; 2008 Jun; 10(6):521-33. PubMed ID: 18516289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination.
    Flockerzi A; Maydt J; Frank O; Ruggieri A; Maldener E; Seifarth W; Medstrand P; Lengauer T; Meyerhans A; Leib-Mösch C; Meese E; Mayer J
    Retrovirology; 2007 Jun; 4():39. PubMed ID: 17550625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HERV-K: the biologically most active human endogenous retrovirus family.
    Tönjes RR; Löwer R; Boller K; Denner J; Hasenmaier B; Kirsch H; König H; Korbmacher C; Limbach C; Lugert R; Phelps RC; Scherer J; Thelen K; Löwer J; Kurth R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S261-7. PubMed ID: 8797733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
    Wilhelm M; Boutabout M; Wilhelm FX
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase.
    Simpson GR; Patience C; Löwer R; Tönjes RR; Moore HD; Weiss RA; Boyd MT
    Virology; 1996 Aug; 222(2):451-6. PubMed ID: 8806530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.
    Fuchs NV; Loewer S; Daley GQ; Izsvák Z; Löwer J; Löwer R
    Retrovirology; 2013 Oct; 10():115. PubMed ID: 24156636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insertional polymorphisms of full-length endogenous retroviruses in humans.
    Turner G; Barbulescu M; Su M; Jensen-Seaman MI; Kidd KK; Lenz J
    Curr Biol; 2001 Oct; 11(19):1531-5. PubMed ID: 11591322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
    George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
    Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses.
    Tönjes RR; Boller K; Limbach C; Lugert R; Kurth R
    Virology; 1997 Jul; 233(2):280-91. PubMed ID: 9217052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.
    Schiavetti F; Thonnard J; Colau D; Boon T; Coulie PG
    Cancer Res; 2002 Oct; 62(19):5510-6. PubMed ID: 12359761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.
    Subramanian RP; Wildschutte JH; Russo C; Coffin JM
    Retrovirology; 2011 Nov; 8():90. PubMed ID: 22067224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human endogenous retrovirus HERV-H family in human tissues and cancer cells: expression, identification, and phylogeny.
    Yi JM; Kim HM; Kim HS
    Cancer Lett; 2006 Jan; 231(2):228-39. PubMed ID: 16399224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
    Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.